Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Conference report: improving outcomes for gastrointestinal cancer in the UK.

Forgacs I, Ashton R, Allum W, Bowley T, Brown H, Coleman MP, Fitzgerald R, Glynn M, Hiom S, Jones R, Machesney M, Maher J, Pereira SP, Steele R, Veitch A, Wyatt S.

Frontline Gastroenterol. 2018 Jan;9(1):49-61. doi: 10.1136/flgastro-2016-100713. Epub 2016 Jun 14. Review. No abstract available.

PMID:
29484161
2.

Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit.

Swann R, McPhail S, Witt J, Shand B, Abel GA, Hiom S, Rashbass J, Lyratzopoulos G, Rubin G; National Cancer Diagnosis Audit Steering Group.

Br J Gen Pract. 2018 Jan;68(666):e63-e72. doi: 10.3399/bjgp17X694169. Epub 2017 Dec 18.

3.

Development and Evaluation of Topical Gabapentin Formulations.

Martin CJ, Alcock N, Hiom S, Birchall JC.

Pharmaceutics. 2017 Aug 30;9(3). pii: E31. doi: 10.3390/pharmaceutics9030031.

4.

Accelerate, Coordinate, Evaluate Programme: a new approach to cancer diagnosis.

Fuller E, Fitzgerald K, Hiom S.

Br J Gen Pract. 2016 Apr;66(645):176-7. doi: 10.3399/bjgp16X684457. No abstract available.

5.

The expanding role of primary care in cancer control.

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C.

Lancet Oncol. 2015 Sep;16(12):1231-72. doi: 10.1016/S1470-2045(15)00205-3. Review.

PMID:
26431866
6.

Diagnosing cancer earlier: reviewing the evidence for improving cancer survival.

Hiom SC.

Br J Cancer. 2015 Mar 31;112 Suppl 1:S1-5. doi: 10.1038/bjc.2015.23. No abstract available.

7.

Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin.

Hiom S, Patel GK, Newcombe RG, Khot S, Martin C.

Br J Dermatol. 2015 Jul;173(1):300-2. doi: 10.1111/bjd.13624. Epub 2015 Jun 2. No abstract available.

PMID:
25524254
8.

A preliminary investigation into the ability of three rapid microbiological methods to detect microorganisms in hospital intravenous pharmaceuticals.

Hiom S, Denyer S, Talbot C, Maillard JY, Spark P, Smith J.

PDA J Pharm Sci Technol. 2013 Jul-Aug;67(4):376-86. doi: 10.5731/pdajpst.2013.00928.

PMID:
23872446
9.

The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.

Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, Vedsted P, Hanson J, Richards M; ICBP Working Group.

Health Policy. 2013 Sep;112(1-2):148-55. doi: 10.1016/j.healthpol.2013.03.021. Epub 2013 May 18.

10.

The impact of automation on workload and dispensing errors in a hospital pharmacy.

James KL, Barlow D, Bithell A, Hiom S, Lord S, Pollard M, Roberts D, Way C, Whittlesea C.

Int J Pharm Pract. 2013 Apr;21(2):92-104. doi: 10.1111/j.2042-7174.2012.00238.x. Epub 2012 Sep 11.

PMID:
23418851
11.

The impact of automation on pharmacy staff experience of workplace stressors.

James KL, Barlow D, Bithell A, Hiom S, Lord S, Oakley P, Pollard M, Roberts D, Way C, Whittlesea C.

Int J Pharm Pract. 2013 Apr;21(2):105-16. doi: 10.1111/j.2042-7174.2012.00231.x. Epub 2012 Aug 6.

PMID:
23418779
12.

Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets.

Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, Richards M.

Br J Cancer. 2012 Oct 9;107(8):1220-6. doi: 10.1038/bjc.2012.408. Epub 2012 Sep 20.

13.

Knowledge of lung cancer symptoms and risk factors in the U.K.: development of a measure and results from a population-based survey.

Simon AE, Juszczyk D, Smyth N, Power E, Hiom S, Peake MD, Wardle J.

Thorax. 2012 May;67(5):426-32. doi: 10.1136/thoraxjnl-2011-200898. Epub 2012 Mar 16.

PMID:
22426791
14.

The Aarhus statement: improving design and reporting of studies on early cancer diagnosis.

Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD.

Br J Cancer. 2012 Mar 27;106(7):1262-7. doi: 10.1038/bjc.2012.68. Epub 2012 Mar 13.

15.

Assessing awareness of colorectal cancer symptoms: measure development and results from a population survey in the UK.

Power E, Simon A, Juszczyk D, Hiom S, Wardle J.

BMC Cancer. 2011 Aug 23;11:366. doi: 10.1186/1471-2407-11-366.

16.

Measuring dispensary workload: a comparison of the event recording and direct time techniques.

James KL, Barlow D, Bithell A, Burfield R, Hiom S, Lord S, Pollard M, Roberts D, Way C, Sutton C, Whittlesea C.

Int J Pharm Pract. 2011 Aug;19(4):264-75. doi: 10.1111/j.2042-7174.2010.00086.x. Epub 2011 Feb 25. Erratum in: Int J Pharm Pract. 2011 Dec;19(6):444.

PMID:
21733014
17.

Unprevented or prevented dispensing incidents: which outcome to use in dispensing error research?

James KL, Barlow D, Burfield R, Hiom S, Roberts D, Whittlesea C.

Int J Pharm Pract. 2011 Feb;19(1):36-50. doi: 10.1111/j.2042-7174.2010.00071.x.

PMID:
21235658
18.

Ethnic disparities in knowledge of cancer screening programmes in the UK.

Robb K, Wardle J, Stubbings S, Ramirez A, Austoker J, Macleod U, Hiom S, Waller J.

J Med Screen. 2010;17(3):125-31. doi: 10.1258/jms.2010.009112.

19.

UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status.

Ashwell M, Stone EM, Stolte H, Cashman KD, Macdonald H, Lanham-New S, Hiom S, Webb A, Fraser D.

Br J Nutr. 2010 Aug;104(4):603-11. doi: 10.1017/S0007114510002138. Epub 2010 Jun 4.

PMID:
20522274
20.

Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study.

Thomson CS, Woolnough S, Wickenden M, Hiom S, Twelves CJ.

BMJ. 2010 Mar 18;340:c877. doi: 10.1136/bmj.c877.

21.

Incidence, type and causes of dispensing errors: a review of the literature.

James KL, Barlow D, McArtney R, Hiom S, Roberts D, Whittlesea C.

Int J Pharm Pract. 2009 Feb;17(1):9-30. Review.

PMID:
20218026
22.

Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England.

Waller J, Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Hiom S, Wardle J.

Br J Cancer. 2009 Dec 3;101 Suppl 2:S24-30. doi: 10.1038/sj.bjc.6605387.

23.

Public awareness of cancer in Britain: a population-based survey of adults.

Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J, Hiom S, Wardle J.

Br J Cancer. 2009 Dec 3;101 Suppl 2:S18-23. doi: 10.1038/sj.bjc.6605386.

24.

Development of a measurement tool to assess public awareness of cancer.

Stubbings S, Robb K, Waller J, Ramirez A, Austoker J, Macleod U, Hiom S, Wardle J.

Br J Cancer. 2009 Dec 3;101 Suppl 2:S13-7. doi: 10.1038/sj.bjc.6605385.

25.

Evaluation of alcohol wipes used during aseptic manufacturing.

Panousi MN, Williams GJ, Girdlestone S, Hiom SJ, Maillard JY.

Lett Appl Microbiol. 2009 May;48(5):648-51. doi: 10.1111/j.1472-765X.2009.02574.x. Epub 2009 Feb 18.

26.

Evaluation of the effectiveness of commercially available contact plates for monitoring microbial environments.

Pinto F, Hiom S, Girdlestone S, Maillard JY.

Lett Appl Microbiol. 2009 Mar;48(3):379-82. doi: 10.1111/j.1472-765X.2008.02534.x. Epub 2009 Feb 2.

27.

The launch of Cancer Research UK's 'Reduce the Risk' campaign: baseline measurements of public awareness of cancer risk factors in 2004.

Redeker C, Wardle J, Wilder D, Hiom S, Miles A.

Eur J Cancer. 2009 Mar;45(5):827-36. doi: 10.1016/j.ejca.2008.10.018. Epub 2008 Dec 4.

PMID:
19054666
28.

Benchmarking the current dispensing rate of Welsh hospital pharmacies.

Hiom S, Roberts D, Hawksbee M, Burfield R, Francis M, Walker K, Lord S, Warner N.

J Clin Pharm Ther. 2006 Aug;31(4):357-62.

PMID:
16882105
29.

Public awareness regarding UV risks and vitamin D--the challenges for UK skin cancer prevention campaigns.

Hiom S.

Prog Biophys Mol Biol. 2006 Sep;92(1):161-6. Epub 2006 Feb 28. Review.

PMID:
16624385
30.

SunSmart? Skin cancer knowledge and preventive behaviour in a British population representative sample.

Miles A, Waller J, Hiom S, Swanston D.

Health Educ Res. 2005 Oct;20(5):579-85. Epub 2005 Jan 11.

31.

A survey of rotational use of biocides in hospital pharmacy aseptic units.

Murtough SM, Hiom SJ, Palmer M, Russell AD.

J Hosp Infect. 2002 Mar;50(3):228-31.

PMID:
11886201
32.

Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria.

Higgins CS, Murtough SM, Williamson E, Hiom SJ, Payne DJ, Russell AD, Walsh TR.

Clin Microbiol Infect. 2001 Jun;7(6):308-15.

33.

Biocide rotation in the healthcare setting: is there a case for policy implementation?

Murtough SM, Hiom SJ, Palmer M, Russell AD.

J Hosp Infect. 2001 May;48(1):1-6. Review. No abstract available.

PMID:
11358464
34.

Bulleidia extructa gen. nov., sp. nov., isolated from the oral cavity.

Downes J, Olsvik B, Hiom SJ, Spratt DA, Cheeseman SL, Olsen I, Weightman AJ, Wade WG.

Int J Syst Evol Microbiol. 2000 May;50 Pt 3:979-83.

PMID:
10843035
36.

Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA.

Marchesi JR, Sato T, Weightman AJ, Martin TA, Fry JC, Hiom SJ, Dymock D, Wade WG.

Appl Environ Microbiol. 1998 Feb;64(2):795-9. Erratum in: Appl Environ Microbiol 1998 Jun;64(6):2333.

38.

Identification and discrimination of oral asaccharolytic Eubacterium spp. by pyrolysis mass spectrometry and artificial neural networks.

Goodacre R, Hiom SJ, Cheeseman SL, Murdoch D, Weightman AJ, Wade WG.

Curr Microbiol. 1996 Feb;32(2):77-84.

PMID:
8574131
39.

The possible role of yeast cell walls in modifying cellular response to chlorhexidine diacetate.

Hiom SJ, Furr JR, Russell AD, Hann AC.

Cytobios. 1996;86(345):123-35.

PMID:
9022261
40.

Uptake of 14C-chlorhexidine gluconate by Saccharomyces cerevisiae, Candida albicans and Candida glabrata.

Hiom SJ, Furr JR, Russell AD.

Lett Appl Microbiol. 1995 Jul;21(1):20-2.

PMID:
7662332
41.

X-ray microanalysis of chlorhexidine-treated cells of Saccharomyces cerevisiae.

Hiom SJ, Hann AC, Furr JR, Russell AD.

Lett Appl Microbiol. 1995 Jun;20(6):353-6.

PMID:
7786500
42.
43.

Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae.

Hiom SJ, Furr JR, Russell AD, Dickinson JR.

J Appl Bacteriol. 1992 Apr;72(4):335-40.

PMID:
1517175

Supplemental Content

Support Center